期刊文献+

不明原因腹水的腹腔镜探查(附32例报告) 被引量:8

Laparoscopic exploration of unknown origin ascites:with a report of 32 cases
下载PDF
导出
摘要 目的:探讨腹腔镜用于探查不明原因腹水的价值。方法:回顾分析1999年6月至2009年6月我院为32例不明原因腹水患者行腹腔镜探查术的临床资料。结果:31例(96.9%)明确了腹水原因,其中肿瘤性腹水17例,结核性腹水12例,出血坏死性肠炎1例,盆腔炎1例;1例未查明病因。结论:不明原因腹水患者病因以恶性肿瘤及结核性腹膜炎为主;腹腔镜探查对诊断腹水病因有较高的实用价值。 Objective:To explore the value of laparoscopic exploration of ascites with uncertain etiology. Methods:We retro- spectively analyzed clinical data of 32 cases of laparoscopie exploration for unknown origin ascites fi'om Jun. 1999 to Jun. 2009 in our hospital. Results : In 32 cases,31 cases (96.9%) were diagnosed definitely. 17 of them were diagnosed as malignant ascites, 12 cases were proved to be tuberculous aseites, 1 case was due to hemorrhagic necrotic enteritis, 1 case was diagnosed as pelvic inflammatory dis- ease, 1 case didnl get final diagnosis. Conclusions:The most common causes of unknown origin ascites were malignant tumor and tuber- culous peritonitis. Laparoseopie exploration plays an important role in diagnosing the etiology of ascites.
机构地区 解放军第
出处 《腹腔镜外科杂志》 2010年第1期45-46,共2页 Journal of Laparoscopic Surgery
关键词 腹水 病因学 腹腔镜检查 Ascites Etiology Laparoscopy
  • 相关文献

参考文献3

二级参考文献26

  • 1[1]Belotti D,Paganoni P,Manenti L,et al.Matrix metaloproteases(MMP9 and MMP2)induce the release of(vascular endothelial growth factor(VEGF)by ovarian carcinoma cells[J].Cancer Res,2003,63(17):3224-3229.
  • 2[2]Geva E,Jaffe RB.Role of vascular,endothelial growth factor in ovarian physiology and pathology)[J].Fertil Steril,2000,74(3):429-443.
  • 3[3]Sartori S,Nielsen I,Tassinari D,et al.Evaluation of a standardized protocol of intracavitary recombinant interferon alpha-2b in the palliative treatment of malignant peritoneac effusions.A prospective pilot study[J].Oncology,2001,61(3):192-196.
  • 4[4]Xu L,Yoneda J,Herrera C,et al.Inhibition of malignant ascites and growth of international joumal of oncology[J].Int J Oncol,2000,16(3):445-454.
  • 5[5]Hasumi Y,Mizukahmi H,Umhe M,et al.Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer[J].Cancer Res,2002,62(7):2019-2023.
  • 6[6]Verheul HM,Hoekman K,Joma AS,et al.Targeting vascular endothelial growth factor blockade:ascites and pleural effusion formation[J].Oncologist,2000,5(suppl):45-50.
  • 7[7]Beanie GJ,Smyth JF.Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites[J].Clin Cancer Res,1998,4(8):1899-1902.
  • 8[8]Macaulay VM,O′Byrne KJ,Saunders MP,et al.Phase I study of malignant pleural effusions[J].Clin Cancer Res,1999,10(3):513-520.
  • 9[9]Low JA,Johnson MD,Bone EA,et al.The matrix metalloproteinase inhibitor BB94 retards human breast cancer solid tumor growth but not ascites formation in hudemice[J].Clin Cancer Res,1996,2(7):1207-1214.
  • 10[10]Kugler A,Stuhler G,Walden P,et al.Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids[J].Nat Med,2000,6(3):332-336.

共引文献29

同被引文献57

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部